NCT02864862

Brief Summary

The purpose of this study is to evaluate the esthetic outcomes following immediate implant combined with the autogenous tissue graft or acellular dermal matrix compared to immediate implant alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2016

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 12, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2021

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

December 16, 2022

Completed
Last Updated

December 16, 2022

Status Verified

November 1, 2022

Enrollment Period

5.1 years

First QC Date

August 9, 2016

Results QC Date

November 21, 2022

Last Update Submit

November 21, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Ridge Dimension

    Change in ridge dimension is calculated as the value at 6 months minus the value at baseline. To take ridge dimension measurements, impressions were taken at baseline and 6 months, models were made from these impressions, the models were scanned, and then ridge dimension of scanned models was assessed using software. Ridge dimension was assessed at (and at 1mm increments below) the initial soft tissue margin.

    baseline, 6 months after surgery

  • Change in Ridge Dimension

    Change in ridge dimension is calculated as the value at 12 months minus the value at baseline. To take ridge dimension measurements, impressions were taken at baseline and 12 months, models were made from these impressions, the models were scanned, and then ridge dimension of scanned models was assessed using software. Ridge dimension was assessed at (and at 1mm increments below) the initial soft tissue margin.

    baseline, 12 months after surgery

Secondary Outcomes (6)

  • Change in Gingival Level

    baseline, 6 months after surgery

  • Change in Gingival Thickness

    baseline, 6 months after surgery

  • Change in Width of Keratinized Gingiva

    baseline, 6 months after surgery

  • Change in Alveolar Bone Level (Marginal)

    baseline, 6 months after surgery

  • Change in Alveolar Bone Level (Crestal)

    baseline, 6 months after surgery

  • +1 more secondary outcomes

Study Arms (3)

Immediate implant

ACTIVE COMPARATOR

Immediate implant alone

Device: Immediate implant

Immediate implant combined with SCTG

ACTIVE COMPARATOR

Subepithelial connective tissue graft (SCTG)

Device: Immediate implantBiological: SCTG

Immediate implant combined with ADM

ACTIVE COMPARATOR

Acellular dermal matrix (ADM)

Device: Immediate implantBiological: ADM

Interventions

Immediate implantImmediate implant combined with ADMImmediate implant combined with SCTG
SCTGBIOLOGICAL
Immediate implant combined with SCTG
ADMBIOLOGICAL
Immediate implant combined with ADM

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients who are in need of a tooth extraction at the maxillary premolar, canine and incisor region, and subsequent single implant placement.
  • The reasons for extraction will include poor endodontic prognosis and/or unrestorable teeth (extensive caries, traumatic fractures, fractures of endodontically treated teeth, root perforation, root resorption with or without radiographic periapical lesion up to 3 mm in diameter). patients who are systemically healthy or with controlled common systemic conditions (controlled hypertension, controlled diabetes HbA1c up to 7 %).
  • adjacent teeth have to be present and the eligible tooth has esthetically acceptable buccal gingival margin position prior to surgery, compared to neighboring teeth and contralateral tooth, and adequate width of buccal keratinized gingiva(≥3mm).
  • level of radiographic bone level has the distance from CEJ to interproximal crest up to 4 mm.
  • Location of buccal alveolar crest has to be generally within 4 mm from the free gingival margin, verified after the extraction, before randomization; and fenestration, if present, up to 3mm in diameter at the apical part of the root and affecting less than 30% of the buccal socket wall.

You may not qualify if:

  • currently smoke exceeding 10 cigarettes/ day
  • severe parafunctional habits, malocclusion or intent of orthodontic therapy in the future and are pregnant.
  • teeth in the surgical site will be excluded if there is advanced periodontal disease or periapical lesion causing significant bony defects that are beyond the criteria mentioned at Section 3.3.
  • allergy to antibiotics contained in the ADM (Gentimicin, Cefoxitin, Lincomcin, polymixin B and Vancomycin) will not be included in the immediate implant combined with ADM group.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Related Publications (1)

  • Jung M, Tran D, Chang CC, Kim SK, Tsukiboshi Y, Min S, Ayilavarapu S, Lee CT. Volumetric buccal bone alterations at immediate implant sites with or without soft tissue augmentation: A 6-month assessment. J Periodontol. 2025 Aug 10. doi: 10.1002/jper.11381. Online ahead of print.

MeSH Terms

Interventions

Immediate Dental Implant Loading

Intervention Hierarchy (Ancestors)

Dental Implantation, EndosseousDental ImplantationOral Surgical Procedures, PreprostheticOral Surgical ProceduresSurgical Procedures, OperativeProsthesis ImplantationDentistryProsthodontics

Results Point of Contact

Title
Chun-Teh Lee
Organization
The University of Texas Health Science Center at Houston

Study Officials

  • Chun-Teh Lee, DDS, DMSc

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 9, 2016

First Posted

August 12, 2016

Study Start

October 1, 2016

Primary Completion

November 22, 2021

Study Completion

November 22, 2021

Last Updated

December 16, 2022

Results First Posted

December 16, 2022

Record last verified: 2022-11

Locations